Description
Grafeel 300mcg Injection is a vital medication used in the management of certain types of cancer, particularly in patients undergoing chemotherapy. The active ingredient in Grafeel is Filgrastim, a recombinant human granulocyte colony-stimulating factor (G-CSF). Filgrastim works by stimulating the bone marrow to produce more white blood cells, specifically neutrophils. This increase in neutrophils is crucial for helping the body fight off infections, which can be a significant risk for individuals with weakened immune systems due to cancer treatments like chemotherapy or radiation therapy. Grafeel is indicated to reduce the incidence of febrile neutropenia (fever and low neutrophil count) in patients with cancer receiving myelosuppressive chemotherapy. It is also used to reduce the duration of neutropenia and the incidence of febrile neutropenia in patients undergoing bone marrow transplantation. The typical dosage and administration schedule are determined by a healthcare professional based on the patient’s condition and treatment plan. Common side effects may include bone pain, headache, fatigue, and injection site reactions. It is essential to store Grafeel 300mcg Injection as directed by the manufacturer, typically refrigerated, and protected from light.
